3-hydroxypyridine has been researched along with erythromycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pratim Roy, P; Roy, K | 1 |
| Bouillon, A; Cresteil, T; Fontaine, F; Hequet, A; Jolivalt, C; Lesnard, A; Rault, S; Voisin-Chiret, AS | 1 |
2 other study(ies) available for 3-hydroxypyridine and erythromycin
| Article | Year |
|---|---|
Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
Topics: Algorithms; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Inhibitors; Factor Analysis, Statistical; Least-Squares Analysis; Linear Models; Models, Molecular; Neural Networks, Computer; Quantitative Structure-Activity Relationship; Reproducibility of Results | 2009 |
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Proteins; Boronic Acids; Cell Survival; Ciprofloxacin; Culture Media; Drug Resistance, Bacterial; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; KB Cells; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Staphylococcus aureus; Structure-Activity Relationship | 2014 |